华语非酒精性脂肪肝患者及其医护人员的耻辱感

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Journal of Hepatology Pub Date : 2024-10-23 DOI:10.1016/j.jhep.2024.10.026

Zobair M. Younossi, Maria Stepanova

{"title":"华语非酒精性脂肪肝患者及其医护人员的耻辱感","authors":"Zobair M. Younossi, Maria Stepanova","doi":"10.1016/j.jhep.2024.10.026","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Abbreviations</h2>Metabolic dysfunction-associated steatotic liver disease (MASLD), non-alcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), metabolic dysfunction-associated fatty liver disease (MAFLD), non-alcoholic steatohepatitis (NASH), metabolic dysfunction-associated steatohepatitis (MASH)”<u>Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a very common liver disease in the general population with an especially high</u></section></section><section><section><h2>Uncited reference</h2>2.; 3.; 4.; 15..</section></section><section><section><h2>Funding</h2>No funding was received for this work.</section></section><section><section><h2>Declaration of Competing Interest</h2>ZMY has received research funding and/or serve as consultant to Intercept, CymaBay, Boehringer Ingelheim, BMS, GSK, NovoNordisk, Ipsen, AstraZeneca, Siemens, Madridgal, Merck and Abbott</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"93 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Stigma Among Chinese Speaking Patients with Non-alcoholic Fatty Liver Disease and Their Providers\",\"authors\":\"Zobair M. Younossi, Maria Stepanova\",\"doi\":\"10.1016/j.jhep.2024.10.026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h2>Section snippets</h2><section><section><h2>Abbreviations</h2>Metabolic dysfunction-associated steatotic liver disease (MASLD), non-alcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), metabolic dysfunction-associated fatty liver disease (MAFLD), non-alcoholic steatohepatitis (NASH), metabolic dysfunction-associated steatohepatitis (MASH)”<u>Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a very common liver disease in the general population with an especially high</u></section></section><section><section><h2>Uncited reference</h2>2.; 3.; 4.; 15..</section></section><section><section><h2>Funding</h2>No funding was received for this work.</section></section><section><section><h2>Declaration of Competing Interest</h2>ZMY has received research funding and/or serve as consultant to Intercept, CymaBay, Boehringer Ingelheim, BMS, GSK, NovoNordisk, Ipsen, AstraZeneca, Siemens, Madridgal, Merck and Abbott</section></section>\",\"PeriodicalId\":15888,\"journal\":{\"name\":\"Journal of Hepatology\",\"volume\":\"93 1\",\"pages\":\"\"},\"PeriodicalIF\":26.8000,\"publicationDate\":\"2024-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jhep.2024.10.026\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2024.10.026","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

章节片段缩写代谢功能障碍相关性脂肪肝（MASLD）、非酒精性脂肪肝（NAFLD）、2 型糖尿病（T2D）、代谢功能障碍相关性脂肪肝（MAFLD）、非酒精性脂肪性肝炎（NASH）、代谢功能障碍相关性脂肪性肝炎（MASH）"代谢功能障碍相关性脂肪性肝病（MASLD），以前称为非酒精性脂肪肝（NAFLD），是普通人群中一种非常常见的肝病，发病率特别高。竞争利益声明ZMY 曾接受 Intercept、CymaBay、勃林格殷格翰、BMS、葛兰素史克、诺和诺德、益普生、阿斯利康、西门子、Madridgal、默克和雅培的研究资助和/或担任其顾问。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Stigma Among Chinese Speaking Patients with Non-alcoholic Fatty Liver Disease and Their Providers

Section snippets

Abbreviations

Metabolic dysfunction-associated steatotic liver disease (MASLD), non-alcoholic fatty liver disease (NAFLD), type 2 diabetes (T2D), metabolic dysfunction-associated fatty liver disease (MAFLD), non-alcoholic steatohepatitis (NASH), metabolic dysfunction-associated steatohepatitis (MASH)”Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a very common liver disease in the general population with an especially high

Uncited reference

2.; 3.; 4.; 15..

Funding

No funding was received for this work.

Declaration of Competing Interest

ZMY has received research funding and/or serve as consultant to Intercept, CymaBay, Boehringer Ingelheim, BMS, GSK, NovoNordisk, Ipsen, AstraZeneca, Siemens, Madridgal, Merck and Abbott

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.